centrally acting agents – hippokratia.gr

The role of moxonidine, a second generation centrally acting antihypertensive agent as antihypertensive therapy in the obese

Posted on March 4, 2019July 26, 2022 by admin

LETTER

Hippokratia 2014, 18(2):189

Karlafti E, Hatzitolios A, Savopoulos Ch
1st Medical Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece